ESOPAug 3, 2026, 04:33 PM
X4 Pharmaceuticals Issues 12,000 Stock Options to New Employees
AI Summary
X4 Pharmaceuticals announced the issuance of inducement awards to new employees, effective July 31, 2026. These awards consist of options to purchase an aggregate of 12,000 shares of common stock, granted under the 2019 Inducement Equity Incentive Plan. The options have a ten-year term, an exercise price of $3.98 per share, and will vest over a four-year period.
Key Highlights
- Issued inducement awards for 12,000 shares of common stock to new employees.
- Options have an exercise price of $3.98 per share, matching July 31, 2026 closing price.
- Options have a ten-year term.
- Vesting over four years: 25% after 12 months, then monthly over 36 months.
- Awards granted under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.
Price Impact
More from XFOR